sever
sepsi
septic
shock
current
among
common
caus
morbid
mortal
intens
care
incid
increas
past
decad
popul
age
emerg
depart
ed
patient
treat
communityacquir
infect
mani
requir
intens
care
unit
icu
manag
identifi
set
syndrom
outcom
may
readili
observ
despit
dramat
improv
diagnost
treatment
procedur
mortal
rate
among
patient
sepsi
remain
unchang
late
diagnost
algorithm
therefor
develop
identifi
atrisk
popul
profession
societi
work
implement
treatment
procedur
focu
effort
earli
intervent
surviv
sepsi
campaign
propos
manag
procedur
differenti
resuscit
bundl
first
hour
manag
bundl
appli
end
hour
procedur
recommend
dissemin
worldwid
focus
global
improv
practic
whose
primari
goal
reduc
sepsisrel
death
consequ
recommend
trend
toward
decreas
mortal
observ
past
year
difficulti
remain
howev
appli
procedur
recommend
expert
articl
summar
main
propos
rais
surviv
sepsi
campaign
focus
difficulti
associ
appli
guidelin
appropri
time
frame
definit
sepsi
sever
sepsi
septic
shock
propos
year
ago
base
expert
advic
use
criteria
identifi
progress
infect
along
appropri
respons
howev
criteria
clearli
inadequ
term
allow
detect
sever
infect
routin
daili
practic
studi
larg
multicent
cohort
icu
patient
infect
conclud
simpli
categor
infecti
process
sepsi
sever
sepsi
predict
prognosi
high
score
indic
septic
condit
necessarili
predict
patient
outcom
even
though
outcom
might
affect
sepsisrel
organ
dysfunct
regard
patient
present
ed
communityacquir
pneumonia
cap
recent
report
dremsizov
cowork
illustr
limit
valu
well
establish
criteria
system
inflammatori
respons
syndrom
sir
predict
outcom
work
emphas
inabl
sir
design
identifi
infect
patient
risk
develop
sever
sepsi
shock
find
prompt
expert
propos
new
score
system
aim
identifi
patient
risk
develop
sever
condit
relat
infect
shapiro
cowork
develop
mortal
emerg
depart
sepsi
med
score
predict
outcom
patient
present
ed
infect
calcul
score
requir
data
immedi
avail
ed
despit
abil
predict
allcaus
death
studi
popul
accuraci
med
score
test
individu
patient
level
use
bedsid
evalu
therefor
tool
use
decis
regard
triag
icu
referr
newli
develop
score
system
appear
margin
util
daili
routin
practic
requir
microbiolog
identif
clinic
evalu
henc
lack
immediaci
requir
decis
make
emerg
medicin
date
pneumonia
sever
index
score
system
consid
help
physician
assess
sever
ill
ed
use
score
bedsid
allow
better
triag
lowrisk
patient
alter
outcom
sever
pneumonia
slightli
effect
inadequ
sir
classif
evalu
biolog
factor
also
may
help
determin
sever
ill
cadi
cowork
propos
use
arteri
blood
lactat
level
identifi
patient
sever
ill
assess
sever
sepsi
surviv
sepsi
campaign
manag
guidelin
committe
american
colleg
chest
physician
societi
critic
care
medicin
consensu
confer
committe
also
propos
guidelin
help
identifi
patient
greater
risk
sepsi
recent
report
shapiro
nguyen
colleagu
emphas
import
lactat
clearanc
identifi
patient
respond
treatment
favor
outcom
lactat
clearanc
shown
better
prognost
factor
singl
lactat
determin
perform
ed
admiss
howev
singl
venou
lactat
measur
mmoll
predict
shortterm
inhospit
risk
death
patient
present
ed
suspect
infect
even
normal
arteri
blood
pressur
singl
lactat
dosag
thu
valuabl
tool
may
facilit
earli
detect
atrisk
patient
plasma
procalcitonin
may
also
valuabl
set
procalcitonin
specif
test
creactiv
protein
help
physician
detect
sepsi
higher
level
procalcitonin
suffici
specif
identifi
septic
patient
develop
sever
sepsi
sensit
enough
routin
use
ed
triag
clear
site
infect
manag
promptli
patient
sever
infect
includ
emerg
surgeri
applic
howev
effort
also
focu
earli
care
control
antimicrobi
therapi
minim
delay
admiss
begin
antimicrobi
treatment
key
achiev
success
outcom
potenti
influenc
delay
antibiot
therapi
first
evalu
patient
cap
seri
medicar
patient
older
year
admit
cap
antibiot
regimen
use
save
live
first
dose
administ
hour
admiss
note
fewer
patient
receiv
antibiot
first
hour
studi
mani
receiv
antimicrobi
treatment
hour
patient
administr
antimicrobi
agent
delay
elderli
peopl
atyp
cap
present
exhibit
clinic
featur
inconsist
diagnosi
sepsi
absenc
fever
alter
mental
statu
specif
patient
diagnosi
infect
obviou
lack
aggress
earli
antimicrobi
therapi
identifi
variou
set
patient
treat
condit
mening
cancer
cap
nosocomi
pneumonia
recent
retrospect
analysi
quantifi
impact
delay
antimicrobi
treatment
patient
sever
sepsi
kumar
cowork
demonstr
everi
addit
hour
without
antibiot
increas
risk
death
hypotens
septic
patient
first
hour
earli
antibiot
therapi
incorpor
surviv
sepsi
campaign
recommend
expect
complianc
compon
guidelin
increas
current
low
level
focu
infect
sometim
difficult
ascertain
treatment
must
effect
target
respons
pathogen
among
wide
rang
potenti
etiolog
agent
initi
select
antimicrobi
agent
good
activ
caus
organ
crucial
surviv
prospect
evalu
sepsi
emphas
comorbid
factor
strongli
associ
death
ineffect
antimicrobi
treatment
microorgan
identifi
blood
cultur
sever
larg
report
corrobor
relat
ineffect
antibiot
treatment
poor
prognosi
consequ
broadspectrum
antibiot
recommend
agent
select
provid
coverag
microorgan
usual
involv
suspect
focu
infect
support
clinic
evid
use
broadspectrum
antibiot
probabl
remain
spars
effect
antimicrobi
manag
requir
good
microbiolog
sens
adher
guidelin
regard
use
antibiot
may
posit
influenc
prognosi
effort
improv
detect
pathogen
continu
enhanc
specif
allow
one
focu
treatment
respons
microorgan
limit
spectrum
coverag
usual
microbiolog
techniqu
detect
may
lack
effect
use
urin
antigen
streptococcu
pneumonia
legionella
pneumophila
type
help
patient
pneumonia
apart
good
sensit
presenc
antigen
detect
long
infect
case
pneumoccoc
relat
infect
may
reflect
carriag
microorgan
upper
respiratori
tract
sensit
genom
tool
avail
detect
bacteria
virus
multiplex
platform
allow
screen
wide
rang
microorgan
posit
techniqu
diagnost
armamentarium
yet
defin
effort
improv
antimicrobi
therapi
must
continu
practic
therefor
outcom
may
improv
futur
among
symptomat
treatment
need
hemodynam
manag
appar
modal
continu
discuss
scientif
literatur
abound
studi
area
effici
restor
circul
blood
volum
primari
goal
resuscit
septic
patient
albumin
first
product
broadli
use
intraven
fluid
load
metaanalysi
compar
albumin
fluid
load
agent
identifi
increas
risk
death
among
patient
receiv
albumin
support
treatment
shock
howev
subgroup
analysi
septic
patient
hypoalbuminemia
reveal
trend
toward
greater
effici
fluid
load
albumin
costbenefit
balanc
anoth
factor
restrict
use
albumin
recent
report
guidet
colleagu
indic
albumin
infus
potenti
costeffect
patient
sepsi
thu
use
albumin
consid
caution
current
lack
support
need
recommend
use
patient
septic
shock
transfus
pack
red
cell
may
also
consid
septic
patient
transfus
hemoglobin
may
contribut
improv
oxygen
transport
deliveri
control
studi
test
option
howev
report
liber
transfus
potenti
ineffect
sinc
public
find
river
cowork
use
pack
red
cell
regard
valuabl
approach
improv
tissu
oxygen
specif
indic
transfus
pack
red
cell
set
remain
unclear
although
controversi
persist
area
preferenti
use
crystalloid
rather
colloid
support
avail
literatur
amount
volum
expans
differ
two
treatment
term
eject
stroke
volum
oxygen
deliveri
systemat
review
metaanalys
includ
patient
sepsi
type
patient
conclud
crystalloid
colloid
gener
similar
effect
except
one
studi
identifi
advantag
crystalloid
find
receiv
support
random
trial
found
patient
septic
shock
receiv
colloid
greater
renal
impair
recent
studi
conduct
compar
colloid
crystalloid
volum
resuscit
aim
identifi
safest
choic
use
patient
sepsi
studi
employ
prospect
random
multicent
design
compar
influenc
outcom
ringer
lactat
versu
hydroxyethyl
starch
intens
versu
convent
insulin
therapi
patient
sever
sepsi
septic
shock
expert
alreadi
critic
studi
ground
design
confound
applic
find
routin
daili
care
summar
although
infus
fluid
cornerston
support
care
sepsi
optim
modal
volum
difficult
determin
choic
driven
object
individu
patient
solid
rational
explain
util
vasopressor
daili
practic
compar
studi
combin
differ
molecul
account
practic
select
combin
norepinephrin
noradrenalin
dobutamin
improv
hemodynam
paramet
hepatosplanchn
circul
requir
invas
monitor
procedur
without
clinic
benefit
dopamin
epinephrin
vasoconstrictor
also
increas
cardiac
output
metabol
effect
may
harm
addit
use
vasopressor
associ
poorer
outcom
septic
patient
influenc
mortal
unclear
assist
physician
use
vasoact
drug
profession
associ
propos
guidelin
allow
opportun
administ
epinephrin
combin
norepinephrin
dobutamin
sever
ill
patient
recent
report
studi
indic
two
strategi
equival
term
efficaci
safeti
interest
vasopressin
reflect
grow
number
public
avail
evid
allow
integr
global
therapeut
scheme
howev
recent
data
may
justifi
reconsider
vasopressin
sever
sepsi
manag
guidelin
near
futur
vasopressin
septic
shock
trial
vasst
studi
current
compar
vasopressin
norepinephrin
initi
vasopressor
septic
shock
patient
studi
yet
complet
analysi
definit
conclus
yet
drawn
trial
whichev
drug
select
introduct
vasopressor
consid
optim
fluid
load
agent
may
allow
therapi
appli
earlier
aggress
order
improv
physiolog
paramet
ultim
outcom
initi
manag
patient
sepsi
improv
physiolog
paramet
blood
pressur
tissu
oxygen
deliveri
clear
goal
emphas
expert
sinc
late
previou
studi
underscor
appli
earli
goaldirect
therapi
egdt
approach
could
improv
surviv
landmark
studi
conduct
river
cowork
emphas
concept
field
sepsi
public
prompt
debat
basic
medic
practic
center
question
possibl
improv
outcom
septic
patient
increas
tissu
oxygen
paramet
first
hour
manag
protocol
propos
river
cowork
involv
attain
physiolog
level
hemodynam
paramet
arteri
blood
pressur
central
venou
oxygen
satur
use
fluid
load
vasopressor
pack
red
cell
earli
initi
mechan
ventil
rapidli
possibl
overwhelmingli
posit
result
egdt
studi
prompt
number
ed
icu
team
chang
daili
care
accord
studi
protocol
paper
report
partial
absolut
adher
procedur
evalu
river
cowork
other
propos
adapt
procedur
medic
system
either
less
aggress
therapi
form
sepsi
team
specif
task
manag
patient
sever
infect
overal
result
report
trend
toward
improv
outcom
septic
patient
howev
find
temper
number
barrier
ed
access
equip
abil
monitor
hemodynam
paramet
invas
vari
wide
anoth
unresolv
issu
ed
physician
necessari
resuscit
skill
administ
optim
treatment
observ
icu
addit
number
recent
report
identifi
fact
ed
increasingli
overburden
compromis
qualiti
care
deliv
patient
especi
requir
highli
technic
care
mani
ed
physician
time
practic
everincreas
number
patient
final
studi
emerg
indic
recommend
implement
earli
administr
antimicrobi
therapi
poorli
adher
even
recent
report
although
surviv
sepsi
campaign
propos
implement
mean
delay
first
infus
antibiot
remain
excess
hour
mani
patient
receiv
first
dose
within
period
egdt
valid
studi
conduct
ed
appli
aggress
treatment
outsid
icu
howev
even
ed
mortal
sometim
remain
institut
procedur
improv
coordin
ed
icu
addit
effort
maintain
initi
egdt
strategi
perform
dramat
decreas
initi
implement
addit
pragmat
therapeut
approach
optim
tool
evalu
attain
physiolog
goal
also
subject
debat
although
valuabl
paramet
abnorm
may
normal
rang
even
sever
septic
patient
hemodynam
present
mani
depend
comorbid
stage
sepsi
addit
central
venou
pressur
may
also
provid
use
inform
low
central
venou
pressur
indic
hypovolemia
high
central
nervou
pressur
low
indic
myocardi
suppress
mismatch
suppli
demand
clinic
situat
find
must
interpret
alongsid
clinic
data
indic
may
help
systol
volum
puls
pressur
variat
also
provid
valuabl
inform
regard
blood
volum
rel
liber
use
pack
red
cell
improv
may
offset
potenti
harm
set
sever
sepsi
septic
shock
theoret
risk
appear
balanc
benefit
term
tissu
oxygen
although
use
central
venou
pressur
evalu
attain
physiolog
goal
debat
clear
defin
reason
goal
treat
sepsi
import
whatev
local
organ
avail
mean
achiev
object
past
two
decad
therapeut
trial
attempt
elicit
chang
host
respons
infect
fail
improv
patient
condit
despit
posit
preclin
data
howev
result
two
recent
studi
led
promis
approach
problem
recombin
human
activ
protein
c
rhapc
lowdos
steroid
hemodynam
effect
steroid
wide
discuss
sinc
use
found
allow
earli
withdraw
vasopressor
treatment
prospect
doubleblind
multicent
studi
posit
effect
steroid
adrenerg
receptor
cycl
sodium
water
balanc
propos
explan
efficaci
antiinflammatori
role
well
anticoagul
effect
caus
limit
membran
express
tissu
factor
may
contribut
clinic
benefit
major
difficulti
lie
defin
adren
defici
septic
shock
patient
number
definit
thu
far
use
recent
retrospect
multicent
cohort
studi
conduct
corticu
studi
group
emphas
import
cortisol
variat
corticotropin
stimul
studi
addit
rais
possibl
deleteri
effect
etomid
hormon
respons
outcom
concern
previous
report
other
specif
point
still
subject
debat
effort
current
made
defin
best
strategi
use
steroid
sepsi
efficaci
rhapc
test
larg
multicent
studi
result
wide
debat
compound
initi
design
compens
deficit
natur
anticoagul
protein
c
sepsi
thu
limit
organ
failur
improv
surviv
septic
shock
patient
sinc
number
studi
demonstr
addit
benefici
effect
complex
interact
inflamm
innat
immun
apoptosi
rhapc
also
protect
anim
healthi
volunt
hypotens
lipopolysaccharid
challeng
similar
find
also
report
prowess
recombin
human
activ
protein
c
worldwid
evalu
sever
sepsi
studi
rapid
improv
hypotens
vasopressor
withdraw
clinic
effect
could
relat
endocrin
modul
adrenomedullin
implic
regard
vasoact
capac
mechan
efficaci
safeti
rhapc
discuss
review
includ
supplement
despit
strong
evid
base
use
adjunct
therapi
remain
spars
set
sepsi
questionnair
survey
attest
underus
adjunct
therapi
need
medic
adher
new
therapi
must
promot
implement
local
guidelin
inspir
recommend
surviv
sepsi
campaign
figur
new
standard
care
low
tidal
volum
mechan
ventil
tight
blood
glucos
control
recent
emerg
cornerston
treatment
critic
ill
patient
low
tidal
volum
mlkg
compar
standard
mechan
ventil
mlkg
improv
surviv
patient
acut
respiratori
distress
syndrom
independ
studi
two
landmark
studi
van
den
bergh
colleagu
suggest
aggress
insulin
therapi
improv
surviv
critic
ill
surgic
patient
reduc
morbid
indic
wean
mechan
ventil
hospit
day
medic
icu
patient
wherea
occurr
manag
hypoglycemia
appear
irrelev
main
paper
addit
data
hypoglycemia
identifi
potenti
caus
harm
other
even
standard
still
discuss
specif
impact
sepsi
may
also
contribut
qualityofcar
improv
final
patient
success
outcom
guidelin
propos
surviv
sepsi
campaign
improv
outcom
septic
patient
difficult
appli
routin
ed
attempt
appli
procedur
fulli
vari
wide
diagnosi
may
problemat
atyp
unspecif
present
biomark
littl
help
start
treatment
unspecif
support
treatment
often
depend
local
suppli
resourc
specif
devic
often
absent
ed
initi
therapi
monitor
even
adher
earli
administr
antibiot
therapi
poor
delay
common
goal
improv
level
care
appli
evidencebas
procedur
cap
communityacquir
pneumonia
ed
emerg
depart
egdt
earli
goaldirect
therapi
icu
intens
care
unit
med
mortal
emerg
depart
sepsi
rhapc
recombin
human
activ
protein
c
central
venou
oxygen
satur
sir
system
inflammatori
respons
syndrom
jfd
investig
prowess
studi
consult
eli
lilli
compani
yec
declar
compet
interest
